RASHMI KRISHNA MURTHY to Granulocyte-Macrophage Colony-Stimulating Factor
This is a "connection" page, showing publications RASHMI KRISHNA MURTHY has written about Granulocyte-Macrophage Colony-Stimulating Factor.
Connection Strength
0.308
-
Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer. Clin Immunol. 2021 04; 225:108679.
Score: 0.164
-
Initial safety analysis of a randomized phase II trial of nelipepimut-S?+?GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer patients with HER2 low-expressing tumors. Clin Immunol. 2019 04; 201:48-54.
Score: 0.144